Abstract:Asian American (24 million people) and Native Hawaiian and other Pacific Islander (1.7 million people) individuals represent 8% of the US population. 1 Cancer is the leading cause of death among many Asian American groups (Chinese, Filipino, Vietnamese, and Korean) and is the second leading cause of death among Native Hawaiian, Indian, and Japanese American people. 1 A growing body of research has focused on cancer among these very diverse groups, elucidating their unique and dynamic cancer risk factors, epidemiology, and access to care. 2 ,3 Zhu et al 4 evaluated cancer-specific mortality (CSM) rates for Asian American, Native Hawaiian, and other Pacific Islander individuals from 1999 to 2020 using the Centers for Disease Control and Prevention's Wide-Ranging Online Data for Epidemiologic Research database. They found that for these groups in aggregate, CSM rates decreased over the past 2 decades and that decreases were greater among men than among women. The CSM rates among women increased for cancers of the uterus and the brain and central nervous system but decreased for other cancer sites. Upon analysis by age, women aged 65 to 74 years experienced the greatest increase in mortality from uterine cancer. Among men, CSM rates decreased overall, with the greatest decreases in cancers of the stomach and lung. Decreases in CSM were greatest in cancers of the liver and lung among men aged 35 to 44 years; however, colorectal cancer mortality increased among men aged 45 to 54 years, and after a decrease from 2002 to 2012, prostate cancer increased among men aged 64 to 74 years (from 2012 to 2020). The authors found increased mortality for pancreatic cancer in the Midwest and for uterine cancer and liver cancer across all US census regions. The study by Zhu et al 4 highlights the need to further study and address the cancer burden among these rapidly growing populations. 1 Their work is nationally representative and may inform cancer policy. Their findings illustrate how cancer mortality has changed over time, reflecting changes in risk factors, screening rates, and timely and equitable access to quality cancer care. 2 -4 The study is limited by the aggregation of diverse Asian American and Pacific Islander groups, who exhibit some of the widest disparities in social determinants of health across census groups, 1 -3 a limitation inherent in the dataset that masks heterogeneity in cancer mortality. 1 -3 Heterogeneity in cancer mortality is notable. The age-adjusted mortality rate for all cancer subsites is 142 per 100 000 for Native Hawaiian and Pacific Islander patients, 91 per 100 000 for Asian American patients, and 153 per 100 000 for White patients. 1 For uterine cancer, the age-adjusted mortality rate is 16 per 100 000 for Native Hawaiian and Pacific Islander patients compared with 5 per 100 000 for White patients and 3 per 100 000 for Asian American patients. 1 For breast cancer, 5-year relative survival is 94% for Japanese American and 93% for White and Chinese patients compared with 72% for Tongan, 73% for Chamorro and Guamanian, and 74% for Samoan patients. 1 For cancers of the lung and bronchus, 5-year relative survival is 37% for Thai, 36% for Chinese, 35% for Pakistani, and 29% for Indian patients compared with 25% for White, 18% for Samoan, 15% for Tongan, and 11% for Laotian patients. 1 Such heterogeneity in mortality may reflect differences across the continuum of disease leading up to mortality estimates. 2 Considering the current study and in the context of such heterogeneity, what are the next steps? First, further disaggregated research is needed to examine the drivers of these temporal changes. Although CSM has decreased overall for Asian American, Native Hawaiian, and Pacific Islander patients, decreases in lung CSM may be driven by relatively better survival among Chinese and Indian patients (and perhaps to a lesser extent by the smaller Thai and Pakistani populations) but may not reflect the substantially lower survival among several Pacific Islander and Southeast Asian (eg, Laotian) groups. 1 Increases in uterine CSM may reflect the burden of disease among Native Hawaiian and Pacific Islander individuals, among whom focused studies and interventions are needed. 1 ,3 Further research could explore how cancer risk compares between immigrants and people in their countries of origin and how cancer risk changes across generations of immigrants. 5 Parallels between immigrants and their countries of origin may inform targeted diagnostics, as exemplified by the high rate of gastric cancer among Korean American individuals reflecting epidemiology in Korea. 1 ,5 Such work may also elucidate how risk changes in th -Abstract Truncated-

Breast cancer incidence and stage at diagnosis in the six US-Affiliated Pacific Islands

Cervical Cancer Incidence in the US-Affiliated Pacific Islands

Recent trends and patterns in breast cancer incidence among Eastern and Southeastern Asian women

Building Capacity for Cervical Cancer Prevention in U.S.-Affiliated Pacific Islands: The Pacific Against Cervical Cancer Project

Illuminating the breast cancer survival rates among Southeast Asian women: A systematic review and meta-analysis spanning four decades

Feasibility of monitoring Global Breast Cancer Initiative Framework key performance indicators in 21 Asian National Cancer Centers Alliance member countries

Disaggregated Cancer Research and Intervention for Asian American and Pacific Islander People

Survival of Filipino women with breast cancer in the United States

Disparities in Colorectal Cancer Incidence among Asian and Pacific Islander Populations in Guam, Hawai'i, and the United States

Global incidence and mortality of breast cancer: a trend analysis

The Fluctuating Incidence, Improved Survival of Patients with Breast Cancer, and Disparities by Age, Race, and Socioeconomic Status by Decade, 1981-2010

Abstract 4821: Lung cancer survival disparities by ethnicity in Guam, 2001-2020

Cervical cancer disparities in stage at presentation for disaggregated Asian Americans, Native Hawaiians, and Pacific Islanders

International Variation in Female Breast Cancer Incidence and Mortality Rates

Abstract A027: Ethnic variations in breast cancer risk factors distribution in Guam, HIPIMR study

Feasibility of Monitoring Global Breast Cancer Initiative Framework Key Performance Indicators in 21 Asian Countries

Global patterns of breast cancer incidence and mortality: A population‐based cancer registry data analysis from 2000 to 2020

Disparities in Breast Cancer Treatment and Reconstruction Among Native Hawaiian and Pacific Islander Women: Systematic Review and Meta‐Analysis

Deciphering the global landscape of breast cancer in 38 OECD countries from 1990-2019: A benchmarking global analysis.

Abstract P4-03-04: The first population level description of all women diagnosed with breast cancer in Costa Rica from 2008 to 2012 using data from the National Tumor Registry

Abstract A102: Nationwide Racial, Ethnic, Geographic and Stage-Specific Trends in Breast Cancer Incidence among Older US Women, 2001-2019